184 results
8-K
EX-10.10
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
short-term or long-term disability or other medical leave) or employment on a less than full-time basis is considered a “Termination of Employment,” (ii
8-K
EX-99.3
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
lease liability, current
Common stock warrant liability
Related party accounts payable and other current liabilities
Total current liabilities
Long term liabilities
424B3
ORKA
Oruka Therapeutics Inc.
1 Aug 24
Prospectus supplement
4:10pm
to the Reverse Stock Split
The reverse stock split may not increase our stock price over the long-term.
The reverse stock split may decrease … .
Risks Related to the Proposed Reverse Stock Split
The reverse stock split may not increase our stock price over the long-term.
The principal purposes
425
djcpdv7kxltf3
6 Jun 24
Business combination disclosure
4:45pm
425
gdmw8xkgu04l9m3t
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
7tn8sxjt1fp0
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-99.1
kf5n9k35vznig45
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-99.3
spij1 t890l02qt
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
EX-99.2
lb05snx
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am